Company: IMNN
Filing Date: 2025-05-19
Form Type: S-1/A
Source: 0001641172-25-011388
Chunk: 14

Company: Imunon, Inc.
Filing Date: 2025-05-19
Form: S-1/A
Chunk 14
---
 by non-affiliates is less than $700 million and our annual revenue was less than $100 million during our most recently completed fiscal year. We may continue to be a smaller reporting company if either (i) the market value of our stock held by non-affiliates is less than $250 million or (ii) our annual revenue was less than $100 million during the most recently completed fiscal year and the market value of our stock held by non-affiliates is less than $700 million. For so long as we remain a smaller reporting company, we are permitted and intend to rely on exemptions from certain disclosure and other requirements that are applicable to other public companies that are not smaller reporting companies.

| 3 |

<div align='center'>THE OFFERING</div>

| Common                                     
 Stock offered by us in this offering       |     | Up                                                                                                                                          
 to 16,666,667 shares of our Common Stock on a “best efforts” basis based on an assumed public offering price of                             
 $0.48 per share and accompanying common warrants, which was the closing price of our Common Stock as reported on Nasdaq on                  
 May 16, 2025.                                                                                                                               |
| Pre-funded                                 
 warrants offered by us in this offering    |     | We                                                                                                                                          
 are also offering to each purchaser whose purchase of shares in this offering would otherwise result in the purchaser, together with        
 its affiliates and certain related parties, beneficially owning more than 4.99% (or, at the election of the purchaser, 9.99%) of our        
 outstanding Common Stock immediately following the consummation of this offering, the opportunity to purchase, if the purchaser so chooses, 
 pre-funded warrants (each pre-funded warrant to purchase one share of our Common Stock) in lieu of shares that would otherwise result       
 in the purchaser’s beneficial ownership exceeding 4.99% of our outstanding Common Stock (or, at the election of the purchaser,              
 9.99%). The purchase price of each pre-funded warrant and accompanying common warrant will equal the price at which one share of Common     
 Stock and accompanying warrant are being sold to the public in this offering, minus $0.0001, and the exercise price of each pre-funded      
 warrant will be $0.0001 per share. The pre-funded warrants will be exercisable immediately and may be exercised at any time until all       
 of the pre-funded warrants are exercised in full. For each pre-funded warrant we sell, the number of shares of Common Stock we are offering